Thromboembolism News and Research

RSS
ThromboView gets positive results in study evaluating accuracy and safety

ThromboView gets positive results in study evaluating accuracy and safety

Study: Cancer patients with VTE do not benefit from IVCF and fondaparinux

Study: Cancer patients with VTE do not benefit from IVCF and fondaparinux

Women with sedentary lifestyle more likely to develop pulmonary embolism

Women with sedentary lifestyle more likely to develop pulmonary embolism

On-X LTI announces four clinical trial results of Prosthetic Heart Valve

On-X LTI announces four clinical trial results of Prosthetic Heart Valve

Low-risk patients with pulmonary embolism can benefit from outpatient care

Low-risk patients with pulmonary embolism can benefit from outpatient care

Study reveals positive impact of Soliris on long-term outcomes in PNH patients

Study reveals positive impact of Soliris on long-term outcomes in PNH patients

Study explores link between hospital procedure volume, surgical outcomes after joint replacements

Study explores link between hospital procedure volume, surgical outcomes after joint replacements

Sanofi's semuloparin Phase III study data against venous thromboembolism presented at ASCO 2011

Sanofi's semuloparin Phase III study data against venous thromboembolism presented at ASCO 2011

Study on entire Swedish population affirms significance of hereditary factors for venous thromboembolism

Study on entire Swedish population affirms significance of hereditary factors for venous thromboembolism

EMAS publishes position statement on women's post-reproductive health problems in Maturitas journal

EMAS publishes position statement on women's post-reproductive health problems in Maturitas journal

Doctors miss blood clots costing millions to the NHS: Report

Doctors miss blood clots costing millions to the NHS: Report

Pelvic imaging using CT exams are not necessary for VTE diagnosis

Pelvic imaging using CT exams are not necessary for VTE diagnosis

Desirudin more effective for VTE prevention in patients with renal impairment

Desirudin more effective for VTE prevention in patients with renal impairment

BioInvent, ThromboGenics initiate TB-402 Phase IIb trial for VTE prophylaxis

BioInvent, ThromboGenics initiate TB-402 Phase IIb trial for VTE prophylaxis

Newer birth control pill raises risk of blood clots

Newer birth control pill raises risk of blood clots

Bayer's oral contraceptives may increase risk of blood clots, stroke or heart attack

Bayer's oral contraceptives may increase risk of blood clots, stroke or heart attack

Bayer's birth control pills may increase risk of venous thromboembolism

Bayer's birth control pills may increase risk of venous thromboembolism

Daiichi Sankyo's LIXIANA receives Japanese marketing approval

Daiichi Sankyo's LIXIANA receives Japanese marketing approval

Contraception drospirenone raises risk for blood clots

Contraception drospirenone raises risk for blood clots

J&JPRD announces rivaroxaban Phase 3 trial results against venous thromboembolism

J&JPRD announces rivaroxaban Phase 3 trial results against venous thromboembolism

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.